((自动化翻译由路透提供，请见免责声明 ))
9月13日 - ** 基因测序设备制造商Illumina 股价上涨1.8%至128.49美元
** 经纪公司加拿大皇家银行资本市场（RBC Capital Markets）将PT值从242美元上调至252美元，股票评级为 "跑赢大盘"。
** 新的预测值比上次收盘价上涨了99.6%。
** 认为该公司目前的股价过分低估了市场份额被较小竞争对手侵蚀的可能性，"没有考虑到多年的研发支出和产品创新"。
** 25 家券商中有 13 家将该股评级为 "买入 "或更高，11 家为 "持有"，1 家为 "卖出"；他们的预测中值为 141 美元
** 包括盘中走势在内，该股今年累计下跌 5.4
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.